TAK ALG-25 (Nesina 25 mg)
Generic Name: alogliptin
Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc..
Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-25
Nesina
- Generic Name
- alogliptin
- Imprint
- TAK ALG-25
- Strength
- 25 mg
- Color
- Red
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64764-0250 | Takeda Pharmaceuticals U.S.A., Inc. |
| 45802-0150 | Perrigo Company |
Related Images for "TAK ALG-25"
More about Nesina (alogliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.